Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Beta Bionics has raised $172.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in September 2026.
Beta Bionics's investors include Wellington Management, Eli Lilly, Perceptive Advisors, Omega Funds, Novo Nordisk.
Beta Bionics is headquartered in Irvine, United States.
Beta Bionics is a biotechnology company that provides software to reduce the burden of diabetes care.
Beta Bionics is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Beta Bionics — Funding & Investors." VCBacked, September 15, 2026, https://www.vcbacked.co/company/beta-bionics. Accessed October 25, 2026.
VCBacked. (2026). Beta Bionics — Funding & Investors. Retrieved October 25, 2026, from https://www.vcbacked.co/company/beta-bionics
{{cite web |title=Beta Bionics — Funding & Investors |url=https://www.vcbacked.co/company/beta-bionics |website=VCBacked |access-date=October 25, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated